Companies given equity injections by EU member states as a result of the coronavirus will not be allowed to pay out dividends, buy back shares, or provide bonuses or similar remuneration, according to an official document seen by the Financial Times.
The terms and conditions emerged after the FT reported last week that the European Commission was exploring a further relaxation of the bloc’s rules on State aid to help ailing companies as a result of the pandemic.
Bailed-out businesses are also forbidden to take “excessive risks” or even engage in “aggressive commercial expansion,” stated a document setting out amendments to the recent relaxation of State aid rules. They will not be able to buy up rivals or other operators in the same sector while still repaying the State, the document added.
The constraints are aimed at preventing “undue distortions of competition” and mirror similar restraints imposed on the banking sector at the height of the global financial crisis more than a decade ago.
European businesses that receive an equity injection of more than 20% from a member State will also be obliged to set up a clear exit strategy from that support in the aftermath of the pandemic.
Brussels is also setting out clear timelines to give companies an incentive to pay back the aid. If by December 31, 2024 the State’s shareholding has not been reduced to below 15%, companies will be obliged to present a restructuring plan to the Commission for approval.
Featured News
Prime Therapeutics Found in Violation of Antitrust Laws, Arbitrator Rules
Jan 23, 2025 by
CPI
Honda and Nissan Face Challenges in China Amid Potential Merger
Jan 23, 2025 by
CPI
Trump Criticizes EU’s Tech Crackdown, Calls It ‘A Form of Taxation’
Jan 23, 2025 by
CPI
Meta Faces Fresh Allegations of EU Law Breaches in Subscription Service Rollout
Jan 23, 2025 by
CPI
European Commission Investigates Crypto Rules for Cross-Border Stablecoins
Jan 23, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Criminal Enforcement
Jan 23, 2025 by
CPI
The Antitrust Division’s Recent Work to Combat International Cartels
Jan 23, 2025 by
Emma Burnham & Benjamin Christenson
Information Sharing: The New Frontier of U.S. Antitrust Enforcement
Jan 23, 2025 by
Brian P. Quinn, Casey Kovarik & Michael Tubach
The Key Role of Guidelines on Exchanges of Information Among Competitors and the Divergent Transatlantic Paths
Jan 23, 2025 by
Rosa Abrantes-Metz & Albert Metz
Leniency, Whistleblowers, and Compliance
Jan 23, 2025 by
Richard Powers, Tara O’Malley & Cory Gordon